ENTRY       K04696                      KO
NAME        SOCS3, CIS3
DEFINITION  suppressor of cytokine signaling 3
PATHWAY     ko04120  Ubiquitin mediated proteolysis
            ko04380  Osteoclast differentiation
            ko04630  Jak-STAT signaling pathway
            ko04668  TNF signaling pathway
            ko04910  Insulin signaling pathway
            ko04917  Prolactin signaling pathway
            ko04920  Adipocytokine signaling pathway
            ko04930  Type II diabetes mellitus
            ko04932  Non-alcoholic fatty liver disease (NAFLD)
            ko05160  Hepatitis C
            ko05164  Influenza A
            ko05168  Herpes simplex infection
MODULE      M00388  ECS complex
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Genetic Information Processing
              Folding, sorting and degradation
               04120 Ubiquitin mediated proteolysis
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
             Environmental Information Processing
              Signal transduction
               04630 Jak-STAT signaling pathway
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
               04668 TNF signaling pathway
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
             Organismal Systems
              Endocrine system
               04910 Insulin signaling pathway
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
               04920 Adipocytokine signaling pathway
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
               04917 Prolactin signaling pathway
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
              Development
               04380 Osteoclast differentiation
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
             Human Diseases
              Endocrine and metabolic diseases
               04930 Type II diabetes mellitus
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
               04932 Non-alcoholic fatty liver disease (NAFLD)
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
              Infectious diseases
               05164 Influenza A
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
               05160 Hepatitis C
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
               05168 Herpes simplex infection
                K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
            KEGG modules [BR:ko00002]
             Structural complex
              Genetic information processing
               Ubiquitin system
                M00388  ECS complex
                 K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
            Ubiquitin system [BR:ko04121]
             Ubiquitin ligases (E3)
              multi subunit Ring-finger type E3
               ECS complex
                target recognizing subunit (SOCS box)
                 K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
GENES       HSA: 9021(SOCS3)
            PTR: 454921(SOCS3)
            PPS: 100978589(SOCS3)
            GGO: 101123839(SOCS3)
            PON: 100446544(SOCS3)
            MCC: 715680(SOCS3)
            MCF: 102121569(SOCS3)
            MMU: 12702(Socs3)
            RNO: 89829(Socs3)
            CGE: 100769267(Socs3)
            HGL: 101704157(Socs3)
            TUP: 102486692(SOCS3)
            CFA: 442949(SOCS3)
            AML: 100475555
            FCA: 101081846(SOCS3)
            BTA: 282081(SOCS3)
            BOM: 102273017(SOCS3)
            PHD: 102315804(SOCS3)
            CHX: 102187711(SOCS3)
            SSC: 493186(SOCS3)
            CFR: 102518913
            BACU: 103013097(SOCS3)
            LVE: 103071774(SOCS3)
            ECB: 100050730(SOCS3)
            MYB: 102252296(SOCS3)
            MYD: 102763837(SOCS3)
            PALE: 102887834(SOCS3)
            MDO: 100026656(SOCS3)
            SHR: 100934360(SOCS3)
            OAA: 100090302(SOCS3)
            GGA: 395299(SOCS3)
            MGP: 100547594
            TGU: 100227853(SOCS3)
            FAB: 101810199(SOCS3)
            PHI: 102107383(SOCS3)
            APLA: 101791200(SOCS3)
            FPG: 101912299(SOCS3)
            FCH: 102058593(SOCS3)
            CLV: 102085285(SOCS3)
            ASN: 102386715(SOCS3)
            AMJ: 102568555(SOCS3) 102570761
            PSS: 102446993(SOCS3)
            CMY: 102930798(SOCS3)
            ACS: 100560082 100564374
            PBI: 103057222 103064119(SOCS3)
            XLA: 380467(socs3) 414533(socs3)
            XTR: 448204(socs3)
            DRE: 406596(socs3b)
            TRU: 101079037 778006(socs-3)
            MZE: 101468895 101479458
            OLA: 101170518(socs3) 101170961(socs3)
            XMA: 102216753 102232586
            LCM: 102346594(SOCS3) 102360670
            CMK: 103175554(socs3)
            BFO: BRAFLDRAFT_63594 BRAFLDRAFT_80045
REFERENCE   PMID:12076535
  AUTHORS   Kile BT, Schulman BA, Alexander WS, Nicola NA, Martin HM, Hilton DJ.
  TITLE     The SOCS box: a tale of destruction and degradation.
  JOURNAL   Trends Biochem Sci 27:235-41 (2002)
REFERENCE   PMID:15601820
  AUTHORS   Kamura T, Maenaka K, Kotoshiba S, Matsumoto M, Kohda D, Conaway RC, Conaway JW, Nakayama KI.
  TITLE     VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
  JOURNAL   Genes Dev 18:3055-65 (2004)
REFERENCE   PMID:12228220
  AUTHORS   Rui L, Yuan M, Frantz D, Shoelson S, White MF.
  TITLE     SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.
  JOURNAL   J Biol Chem 277:42394-8 (2002)
///
